TETERBORO, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Surya N. Mohapatra, Ph.D., President
and Chief Operating Officer, is scheduled to speak at the Merrill Lynch Health
Services Investor Conference on Wednesday, December 3, 2003, at The Waldorf
Astoria in New York City. The Quest Diagnostics presentation is scheduled to
begin at 9:15 a.m. Eastern Time.
The presentation will be webcast live during the conference and will be
available to registered investors on the following site:
http://www.wallstreetwebcasting.com/webcast/ml18/dgx/ and to the public on:
http://www.questdiagnostics.com. In addition, the archived webcast will be
available starting approximately 24 hours after the live event for 14 days.
Quest Diagnostics Incorporated is the nation's leading provider of
diagnostic testing, information and services, providing insights that enable
physicians, hospitals, managed care organizations and other healthcare
professionals to make decisions to improve health. The company offers the
broadest access to diagnostic laboratory services through its national network
of laboratories and patient service centers. Quest Diagnostics is the leading
provider of esoteric testing, including gene-based medical testing, and
empowers healthcare organizations and clinicians with state-of-the-art
connectivity solutions that improve practice management. Additional company
information can be found on the Internet at: http://www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, unanticipated expenditures, changing
relationships with customers, payers, suppliers and strategic partners,
competitive environment, changes in government regulations, conditions of the
economy and other factors described in the Quest Diagnostics Incorporated 2002
Form 10-K and subsequent filings.
SOURCE Quest Diagnostics Incorporated
-0- 12/02/2003
/CONTACT: Investors - Laure Park, +1-201-393-5030, or Media - Gary
Samuels, +1-201-393-5700, both of Quest Diagnostics Incorporated/
/Web site: http://www.questdiagnostics.com
http://www.wallstreetwebcasting.com/webcast/ml18/dgx /
(DGX)